The "Short" opinion expressed is on a mere technical, and medium term, factor.
JNJ is one of the top rating notch in USA with an AAA. In or view the company is really well managed with an interesting dividend yeld of 2.9%.
In 2018 we still belive that earning per share could reach 7.00 dollars, and in 2019 8.00 dollars; the Vision Care and the Surgery business could lead this earnings improvement.
Total debt: 32.5 bill.
Annual net profit: 16.6 bill.
JNJ is one of the top rating notch in USA with an AAA. In or view the company is really well managed with an interesting dividend yeld of 2.9%.
In 2018 we still belive that earning per share could reach 7.00 dollars, and in 2019 8.00 dollars; the Vision Care and the Surgery business could lead this earnings improvement.
Total debt: 32.5 bill.
Annual net profit: 16.6 bill.